Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Syncona (SYNC)

Price 149.40p on 24-03-2023 at 18:01:50
Change -0.60p -0.4%
Buy 151.00p
Sell 150.20p
Buy / Sell SYNC Shares
Last Trade: Unknown 1,500.00 at 148.372p
Day's Volume: 271,203
Last Close: 149.40p
Open: 147.20p
ISIN: GG00B8P59C08
Day's Range 147.00p - 151.00p
52wk Range: 136.20p - 213.00p
Market Capitalisation: £1,000m
VWAP: 149.03707p
Shares in Issue: 669m

Recent Trades History Syncona (SYNC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,500 148.372p Ordinary
Currency Conversion
18:01:37 - 24-Mar-23
Unknown* 1,326 149.40p Ordinary
Currency Conversion
18:01:29 - 24-Mar-23
Unknown* 127 149.408p Ordinary
Currency Conversion
OTC Trade
17:09:56 - 24-Mar-23
Sell* 1,094 149.40p Automatic Execution
16:35:05 - 24-Mar-23
Sell* 19 149.40p Automatic Execution
16:35:05 - 24-Mar-23
Sell* 148,879 149.40p Uncrossing Trade
16:35:05 - 24-Mar-23
Buy* 103 150.80p Automatic Execution
16:23:24 - 24-Mar-23
Sell* 2,674 150.1457p Ordinary
16:19:09 - 24-Mar-23
Buy* 762 151.00p Automatic Execution
16:07:20 - 24-Mar-23
Buy* 101 150.60p Automatic Execution
16:06:00 - 24-Mar-23

Share Price History for Syncona

Time period:
Date Open High Low Close Volume

Share News for Syncona

SUMMARY: London listings with exposure to Silicon Valley Bank

13th Mar 2023 12:18

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Syncona net asset value falls on "challenging" market, dollar weakness

7th Feb 2023 09:45

(Alliance News) - Syncona Ltd on Tuesday reported a decline in its third quarter net asset value, noting a depreciating US dollar against sterling and a decline in the share price of investees. Read More

Life Science REIT lets second floor of Rolling Stock Yard in London

25th Jan 2023 12:14

(Alliance News) - Life Science REIT PLC on Wednesday said it signed an agreement to lease the second floor of its Rolling Stock Yard asset near King's Cross, London, to a life science company backed by Syncona Ltd. Read More

Syncona portfolio firm hits 70% remission rate goal in leukaemia trial

9th Dec 2022 10:36

(Alliance News) - Syncona Ltd on Friday said portfolio company Autolus Therapeutics PLC achieved the primary endpoint in the clinical trial of its treatment for acute lymphoblastic leukaemia. Read More

Syncona investee Achilles continues to progress cancer trials

6th Dec 2022 12:00

(Alliance News) - Syncona Ltd on Tuesday noted the continued positive progress in lung cancer trials by its portfolio company. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered